Sign in
4

Changes in Ownership

PHIBRO ANIMAL HEALTH CORP Filed Acc 0001104659-26-028472

President and CEO sold 5,280 shares at $48.91 ($258,245)

  • President and CEO acquired 100,000 shares (conversion)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENDHEIM JACK · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-12 Conversion : show line 1 in the form 10b5-1 +100,000 101,480 I
2026-03-13 Sale : show line 2 in the form 10b5-1 −5,280 $48.91 $258,245 96,200 I
Open-market sales · 5,280 sh · avg $48.91 · $258,245

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-12 Conversion : show line 3 in the form 10b5-1 Class B Common Stock −100,000 19,596,034 I
Loading xslF345X05/tm268840-1_4seq1.xml…